Table 5.
Cox proportional hazards model for mortality risk for patients treated with amantadine according to admission time groups.
| Cox proportional hazards model for mortality |
||||
|---|---|---|---|---|
| P-value | HR | Lower 95% CI HR value | Upper 95% CI HR value | |
| Remdesivir admission, Yes |
0.649 | 1.114 | 0.700 | 1.774 |
| Tocilizumab admission, Yes |
0.099 | 0.668 | 0.414 | 1.078 |
| Amantadine admission time, >5 day |
0.050 | 0.560 | 0.313 | 0.999 |
| Gender, Male |
0.309 | 1.275 | 0.799 | 2.036 |
| Hypertension, Yes |
0.717 | 1.089 | 0.686 | 1.730 |
| Heart failure, Yes |
0.405 | 1.377 | 0.649 | 2.924 |
| Diabetes, Yes |
0.322 | 0.783 | 0.482 | 1.271 |
| Obesity, Yes |
0.361 | 1.235 | 0.785 | 1.942 |
Abbreviation: HR, Hazard ratio.